DUBLIN--(BUSINESS WIRE)--The "Global Malaria Clinical Trial Pipeline Highlights - 2019" report has been added to ResearchAndMarkets.com's offering.
Malaria Pipeline Highlights - 2019, provides most up-to-date information on key pipeline products in the global Malaria market. It covers emerging therapies for Malaria in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
Clinical Trial Stages:
The report provides Malaria pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.
Drug Mechanism Classes:
The report provides Malaria pipeline products by their dominant mechanism of action/drug class. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.
Company:
The report provides Malaria pipeline products by the company.
Short-term Launch Highlights:
Find out which Malaria pipeline products will be launched in the US and Ex-US till 2024.
Summary:
- Malaria phase 3 clinical trial pipeline products
- Malaria phase 2 clinical trial pipeline products
- Malaria phase 1 clinical trial pipeline products
- Malaria preclinical research pipeline products
- Malaria discovery stage pipeline products
- Malaria pipeline products short-term launch highlights
Key Topics Covered:
1. Malaria Pipeline by Stages
2. Malaria Phase 3 Clinical Trial Insights
3. Malaria Phase 2 Clinical Trial Insights
4. Malaria Phase 1 Clinical Trial Insights
5. Malaria Preclinical Research Insights
6. Malaria Discovery Stage Insights
7. Appendix
8. Research Methodology
For more information about this report visit https://www.researchandmarkets.com/r/gg5uj9
